The acceptability and feasibility of large-scale testing with lateral flow tests (LFTs) for clinical
and public health purposes has been demonstrated during the COVID-19 pandemic. LFTs …

Since its first discovery in December 2019, the global coronavirus disease 2019 (COVID-19)
pandemic caused by the novel coronavirus (SARS-CoV-2) has been posing a serious threat …

The development of reliable and robust diagnostic tests is one of the most efficient methods
to limit the spread of coronavirus disease 2019 (COVID-19), which is caused by the severe …

The outbreak of the coronavirus disease 2019 (COVID-19) has resulted in enormous losses
worldwide. Through effective control measures and vaccination, prevention and curbing …

Bacteria, viruses, and parasites are harmful microorganisms that cause infectious diseases.
Early detection of diseases is critical to prevent disease transmission and provide epidemic …

The SARS-CoV-2 pandemic has created an unprecedented need for rapid diagnostic testing
to enable the efficient treatment and mitigation of COVID-19. The primary diagnostic tool …

Lateral flow tests are one of the most important types of paper-based point-of-care (POCT)
diagnostic tools. It shows great potential as an implement for improving the rapid screening …

Abstract Background Lateral flow devices (LFDs) are viral antigen tests for the detection of
SARS-CoV-2 that produce a rapid result, are inexpensive and easy to operate. They have …

Point-of-care testing (POCT) allows physicians to detect and diagnose diseases at or near
the patient site, faster than conventional lab-based testing. The importance of POCT is …

Lateral flow devices (LFDs) are quickly being implemented for use in large-scale population
surveillance programs for SARS-CoV-2 infection in the United Kingdom. These programs …